ADB International Group (OTCMKTS:EQUR – Get Free Report) and Edap Tms (NASDAQ:EDAP – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.
Profitability
This table compares ADB International Group and Edap Tms’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ADB International Group | N/A | N/A | N/A |
| Edap Tms | -41.24% | -100.07% | -37.38% |
Institutional and Insider Ownership
62.7% of Edap Tms shares are held by institutional investors. 79.6% of ADB International Group shares are held by company insiders. Comparatively, 0.2% of Edap Tms shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ADB International Group | 0 | 0 | 0 | 0 | 0.00 |
| Edap Tms | 1 | 2 | 1 | 0 | 2.00 |
Edap Tms has a consensus target price of $6.00, indicating a potential upside of 71.92%. Given Edap Tms’ stronger consensus rating and higher possible upside, analysts plainly believe Edap Tms is more favorable than ADB International Group.
Valuation & Earnings
This table compares ADB International Group and Edap Tms”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ADB International Group | N/A | N/A | N/A | N/A | N/A |
| Edap Tms | $70.53 million | 1.85 | -$29.25 million | ($0.77) | -4.53 |
ADB International Group has higher earnings, but lower revenue than Edap Tms.
Summary
Edap Tms beats ADB International Group on 5 of the 9 factors compared between the two stocks.
About ADB International Group
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.
About Edap Tms
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
Receive News & Ratings for ADB International Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADB International Group and related companies with MarketBeat.com's FREE daily email newsletter.
